UniProt ID | KAT2A_HUMAN | |
---|---|---|
UniProt AC | Q92830 | |
Protein Name | Histone acetyltransferase KAT2A | |
Gene Name | KAT2A {ECO:0000312|HGNC:HGNC:4201} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 837 | |
Subcellular Localization | Nucleus . Chromosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Mainly localizes to the nucleus. Also localizes to centrosomes in late G1 and around the G1/S transition, coinciding with the onset of centriole formation. | |
Protein Description | Protein lysine acyltransferase that can act both as a acetyltransferase and succinyltransferase, depending on the context. [PubMed: 29211711 Acts as a histone lysine succinyltransferase: catalyzes succinylation of histone H3 on 'Lys-79' (H3K79succ), with a maximum frequency around the transcription start sites of genes] | |
Protein Sequence | MAEPSQAPTPAPAAQPRPLQSPAPAPTPTPAPSPASAPIPTPTPAPAPAPAAAPAGSTGTGGPGVGSGGAGSGGDPARPGLSQQQRASQRKAQVRGLPRAKKLEKLGVFSACKANETCKCNGWKNPKPPTAPRMDLQQPAANLSELCRSCEHPLADHVSHLENVSEDEINRLLGMVVDVENLFMSVHKEEDTDTKQVYFYLFKLLRKCILQMTRPVVEGSLGSPPFEKPNIEQGVLNFVQYKFSHLAPRERQTMFELSKMFLLCLNYWKLETPAQFRQRSQAEDVATYKVNYTRWLCYCHVPQSCDSLPRYETTHVFGRSLLRSIFTVTRRQLLEKFRVEKDKLVPEKRTLILTHFPKFLSMLEEEIYGANSPIWESGFTMPPSEGTQLVPRPASVSAAVVPSTPIFSPSMGGGSNSSLSLDSAGAEPMPGEKRTLPENLTLEDAKRLRVMGDIPMELVNEVMLTITDPAAMLGPETSLLSANAARDETARLEERRGIIEFHVIGNSLTPKANRRVLLWLVGLQNVFSHQLPRMPKEYIARLVFDPKHKTLALIKDGRVIGGICFRMFPTQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKHNILYFLTYADEYAIGYFKKQGFSKDIKVPKSRYLGYIKDYEGATLMECELNPRIPYTELSHIIKKQKEIIKKLIERKQAQIRKVYPGLSCFKEGVRQIPVESVPGIRETGWKPLGKEKGKELKDPDQLYTTLKNLLAQIKSHPSAWPFMEPVKKSEAPDYYEVIRFPIDLKTMTERLRSRYYVTRKLFVADLQRVIANCREYNPPDSEYCRCASALEKFFYFKLKEGGLIDK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAEPSQAPT ------CCCCCCCCC | 37.09 | 22814378 | |
5 (in isoform 2) | Phosphorylation | - | 30.40 | 29116813 | |
9 | Phosphorylation | AEPSQAPTPAPAAQP CCCCCCCCCCCCCCC | 34.79 | 29507054 | |
13 (in isoform 2) | Phosphorylation | - | 22.34 | 29116813 | |
33 | Phosphorylation | PTPTPAPSPASAPIP CCCCCCCCCCCCCCC | 34.89 | - | |
36 | Phosphorylation | TPAPSPASAPIPTPT CCCCCCCCCCCCCCC | 37.65 | - | |
82 | Phosphorylation | DPARPGLSQQQRASQ CCCCCCCCHHHHHHH | 31.68 | 25106551 | |
194 | Phosphorylation | HKEEDTDTKQVYFYL CCCCCCCHHHHHHHH | 26.01 | 20860994 | |
228 | Sumoylation | LGSPPFEKPNIEQGV CCCCCCCCCCHHHHH | 43.68 | - | |
272 | Phosphorylation | LNYWKLETPAQFRQR HHHHHCCCHHHHHHH | 34.07 | - | |
289 (in isoform 1) | Ubiquitination | - | 21.46 | 21890473 | |
289 | Ubiquitination | AEDVATYKVNYTRWL HHHCCCCEECEEEEE | 21.46 | 22817900 | |
307 | Phosphorylation | HVPQSCDSLPRYETT CCCCCCCCCCCCCCH | 44.60 | - | |
372 | Phosphorylation | EEIYGANSPIWESGF HHHHCCCCCCHHCCC | 19.75 | - | |
415 | Phosphorylation | SPSMGGGSNSSLSLD CCCCCCCCCCCCCCC | 36.49 | 30631047 | |
446 | Ubiquitination | NLTLEDAKRLRVMGD CCCHHHHHHHHEECC | 65.37 | 29967540 | |
549 | Acetylation | LVFDPKHKTLALIKD HHCCCCCCEEEEEEC | 51.89 | 54843203 | |
555 | Ubiquitination | HKTLALIKDGRVIGG CCEEEEEECCEEEEE | 55.79 | - | |
669 | Ubiquitination | TELSHIIKKQKEIIK HHHHHHHHHHHHHHH | 48.85 | 29967540 | |
676 | Methylation | KKQKEIIKKLIERKQ HHHHHHHHHHHHHHH | 47.38 | 19351588 | |
677 | Methylation | KQKEIIKKLIERKQA HHHHHHHHHHHHHHH | 44.26 | 19351588 | |
688 | Ubiquitination | RKQAQIRKVYPGLSC HHHHHHHHHCCCCHH | 47.99 | 33845483 | |
690 | Phosphorylation | QAQIRKVYPGLSCFK HHHHHHHCCCCHHHH | 8.46 | 29496907 | |
697 | Ubiquitination | YPGLSCFKEGVRQIP CCCCHHHHHCCCCCC | 58.86 | 33845483 | |
707 | Phosphorylation | VRQIPVESVPGIRET CCCCCHHCCCCCCCC | 33.57 | 22210691 | |
714 | Phosphorylation | SVPGIRETGWKPLGK CCCCCCCCCCCCCCH | 38.19 | 22210691 | |
717 | Acetylation | GIRETGWKPLGKEKG CCCCCCCCCCCHHCC | 31.54 | 26051181 | |
721 | Acetylation | TGWKPLGKEKGKELK CCCCCCCHHCCCCCC | 65.03 | 7304083 | |
721 | Ubiquitination | TGWKPLGKEKGKELK CCCCCCCHHCCCCCC | 65.03 | 29967540 | |
725 | Ubiquitination | PLGKEKGKELKDPDQ CCCHHCCCCCCCHHH | 71.58 | 29967540 | |
725 | Acetylation | PLGKEKGKELKDPDQ CCCHHCCCCCCCHHH | 71.58 | 26051181 | |
728 | Ubiquitination | KEKGKELKDPDQLYT HHCCCCCCCHHHHHH | 69.20 | 29967540 | |
728 | Sumoylation | KEKGKELKDPDQLYT HHCCCCCCCHHHHHH | 69.20 | 28112733 | |
734 | Phosphorylation | LKDPDQLYTTLKNLL CCCHHHHHHHHHHHH | 7.64 | 25159151 | |
735 | Phosphorylation | KDPDQLYTTLKNLLA CCHHHHHHHHHHHHH | 33.96 | 25884760 | |
736 | Phosphorylation | DPDQLYTTLKNLLAQ CHHHHHHHHHHHHHH | 23.37 | 28152594 | |
759 | Ubiquitination | PFMEPVKKSEAPDYY CCCCCCCCCCCCCCH | 54.48 | 33845483 | |
759 | Sumoylation | PFMEPVKKSEAPDYY CCCCCCCCCCCCCCH | 54.48 | 28112733 | |
776 | Ubiquitination | IRFPIDLKTMTERLR EEEECCHHHHHHHHH | 32.28 | - | |
787 | Phosphorylation | ERLRSRYYVTRKLFV HHHHHHHHHHHHHHH | 8.34 | - | |
791 | Ubiquitination | SRYYVTRKLFVADLQ HHHHHHHHHHHHHHH | 36.59 | - | |
791 | Sumoylation | SRYYVTRKLFVADLQ HHHHHHHHHHHHHHH | 36.59 | 28112733 | |
830 | Acetylation | KFFYFKLKEGGLIDK HHHHEEHHHCCCCCC | 55.70 | 26051181 | |
830 | Ubiquitination | KFFYFKLKEGGLIDK HHHHEEHHHCCCCCC | 55.70 | 33845483 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KAT2A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KAT2A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-734, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-734, AND MASSSPECTROMETRY. |